Tirzepatide-Reference-Cited by-同舟云学术

Tirzepatide

Published:2022-09-29 Issue: Volume: Page:001857872211257
ISSN:0018-5787
Container-title:Hospital Pharmacy
language:en
Short-container-title:Hosp Pharm

Author:

Baker Danial E.¹^ORCID,Walley Kaitlyn¹,Levien Terri L.¹^ORCID

Affiliation:

1. Washington State University, Spokane, WA, USA

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Pharmacology,Pharmacy

Link

http://journals.sagepub.com/doi/pdf/10.1177/00185787221125724

Reference40 articles.

1. Mounjaro (tirzepatide) [prescribing information]. Indianapolis, IN: Lilly USA LLC; May 2022.

2. Tirzepatide Once Weekly for the Treatment of Obesity

3. McDermid E. A quick guide to the SURPASS and SURMOUNT trials: phase 3 trials of tirzepatide in type 2 diabetes and obesity. Medicine Matters: Diabetes. Updated 2022. Accessed June 23, 2022. https://diabetes.medicinematters.com/tirzepatide/type-2-diabetes/a-quick-guide-to-the-surpass-and-surmount-trials/18478154

4. National Institutes of Health. Tirzepatide. ClinicalTrials.gov. Accessed June 10, 2022. https://www.clinicaltrials.gov/ct2/results?cond=&term=tirzepatide&cntry=&state=&city=&dist=

5. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-Home Management of Diabetes and Obesity;Home Healthcare Now;2024-01

2. A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide;Cureus;2024-01-01

3. A Comprehensive Review on Weight Loss Associated with Anti-Diabetic Medications;Life;2023-04-14